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ABSTRACT
In Sri Lanka, the active promotion of chemical products to prevent disease in shrimp hatcheries
has led to an increase in the use of drugs and chemicals without much emphasis on understanding
their efficacies.  A survey was carried out to evaluate trends in the use of drugs and chemicals as
therapeutic treatments for shrimp-hatchery diseases.  A wide range of chemicals and drugs are
being used, both for prophylactic treatment and to prevent or control parasitic, fungal and bacterial
diseases in hatcheries.  Without proper scientific investigation into treatment regimes, there has
been a tendency for individual hatcheries to select their own treatment regimes and to do their
own experimentation.  Little knowledge exists among hatchery operators as to the hazardous
effects of the chemicals in use.  Lack of legislation on the use of chemotherapeutants in aquaculture
has led to the uncontrolled use and improper selection of chemicals for use in shrimp hatcheries.
INTRODUCTION
Within the past decade, shrimp culture has progressed at a very rapid pace in Sri Lanka.  At present,
shrimp farming is done mainly in the northwestern coastal areas; however, it continues to expand
into other regions, viz, the eastern and southern coastal areas.  Around 3000 ha of land area have
been allocated for the industry in the northwestern coastal areas, and the production of shrimp in
1995 was around 3,500 mt live weight.  Shrimp farming as practiced in Sri Lanka is monostock
monoculture of the black tiger prawn (Penaeus monodon).  The entire industry is dependent on
hatchery-bred postlarvae for the seed supply.  With the rapid expansion of shrimp grow-out, the
hatchery industry has progressed rapidly during the last few years.  The shrimp hatchery industry
has developed on different levels of economic and management scale.  One of the areas in which a
technical base is lacking is the therapeutic treatment of shrimp-hatchery diseases.  The active
promotion of chemical products has partly led to an increase in use of drugs and chemicals in
shrimp hatcheries without much emphasis on determining their efficacies.
This paper summarizes general trends in the use of drugs and chemotherapeutic agents for treatment
and prevention of diseases in the shrimp hatcheries of Sri Lanka.  It reviews the diseases occurring
in shrimp hatcheries, the clinical signs of diseases treated with chemicals, the chemotherapeutic
agents used, problems and constraints associated with their use, legislation related to their use, and
provides some recommendations.
METHODS
This survey was conducted during August 1995 to May, 1996.  Of the 45 operating hatcheries, 36
(80%) were surveyed.  Information pertaining to the use of drugs and chemicals to treat shrimp-
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hatchery diseases and on the clinical signs of disease was collected based on a questionnaire.  The
questionnaire was designed to collect information on the use of drugs and chemotherapeutic agents
for broodstock maintenance and larval and nursery rearing, and on the technical capabilities of
hatchery personnel.  This information is presented in tabular form and is compared with that
found in the literature.
RESULTS
Diseases Recorded and Clinical Signs Observed
Monodon baculovirus (MBV) has been recorded from these hatcheries.  According to unconfirmed
reports, there have been viral infections due to viruses other than MBV.  Larval mycosis was
commonly found in zoeal and mysis stages, causing mortalities of up to 100%.  Gross signs were
pale yellowish-green colored tissues in the larval body.  The phycomycete fungus Lagenidium sp.
is believed to be the pathogenic agent.
Commonly seen pathogenic bacteria include Vibrio spp., the species suspected to be involved
being V. vulnificus, V. parahaemolyticus, and V. angullarum.  The clinical signs of vibriosis are the
necrosis of appendages with melanized tips, resulting in dark oral regions.  Clear red lesions could
be seen on the cuticle of Vibrio-affected shrimp at the mysis stage.  Luminous bacteria causing up
to 100% larval mortality were recorded in most of the surveyed hatcheries.  Vibrio harveyi is
believed to be the pathogenic agent involved.  Filamentous bacteria were also reported from most
of the surveyed hatcheries.  Heavily infected larvae show discoloration of the body and gills.  The
main filamentous bacteria is Leucothrix  mucor.  It frequently occurs with other genera such as
Flexibacter, Cytophaga, and Flavobacter, which contribute as fouling organisms.
Zoothamnium, Epistylis and Vorticella are the main protozoan genera that were involved as external
fouling organisms.  The suctorians Acinita and Ephelota were also seen.  These types of infection
cause problems in respiration, locomotion, feeding and molting.  These organisms are responsible
for black and brown discoloration of gills.  Heavy infections may show a “fungus-like” appearance
on the body surface and may lead to mortality.
Drugs and Chemotherapeutants used in Hatcheries
Chemicals widely used to control parasites in Sri Lankan shrimp hatcheries include formalin,
malachite green, and formalin and malachite green in combination.  Sixty percent of the hatcheries
surveyed used formalin and 40% used malachite green to control parasites in broodstock holding
facilities.  Twenty seven percent of the hatcheries used malachite green and formalin in combination,
in addition to using malachite green and formalin alone (Table 1).  Of the hatcheries using formalin
and malachite green in larval rearing facilities, 90% and 50%, respectively, used these chemicals to
control parasitic infections (Table 2).
A wide range of drugs and chemotherapeutic agents are used to control bacteria in the shrimp
hatcheries surveyed.  Furans, oxytetracycline, erythromycin and Treflan were widely used with
varying success to control all types of bacteria (Table 2).  Twenty percent of the hatcheries used the
first three drugs in broodstock maintenance to prevent possible bacterial infections after eye stalk
ablation (Table 1).   Eleven percent of the hatcheries used copper compounds, and of the formalin
users, 10% used formalin to control filamentous bacteria, while 16% of the malachite green users
used this dye to control luminous bacteria (Table 2).
Treflan, malachite green and furans have been used as antifungal agents.  Of the hatcheries using
Treflan and malachite green, 63.6% of the Treflan users and 33% of the malachite green users used
these drugs as antifungal agents in larval rearing (Table 2).  For broodstock, the commonly used
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Table 1. Prophylactic treatment used for broodstock maintenance in Penaeus monodon hatcheries in Sri
Lanka.
________________________________________________________________________________________________________________________________________________________________
% Hatcheries        Drug  Dosage range (ppm) Pathogen
40% Malachite green NA Fungi, epibionts
20% Furazan, furazolidone 1.1-5 (2 d) After eye ablation for possible
Oxytetracycline 10   bacterial infections
Erythromycin 0.4
60% Formalin 200 (10 min) Ectoparasites
10-25 (few h) Epibionts
0.25 (indefinite bath) Ciliates
27% Malachite green 1.4-2 malachite green Ectoparasites, epibionts,
  + formalin   + formalin   fungi, and ciliates
15% None - -
________________________________________________________________________________________________________________________________________________________________
Table 2. Chemotherapeutants and their usage for treating larvae and postlarvae in shrimp hatcheries in
Sri Lanka (percentage of user hatcheries using a given chemical to treat against each pathogen
is given in parentheses).
________________________________________________________________________________________________________________________________________________________________
Chemical % Users Dose (ppm) Pathogen
Chloramphenicol 11% 10-15 Luminous bacteria (50%)
3-4 Vibrio spp. (50%)
Copper control 11% 0.0004-22  Filamentous bacteria (11%)
0.24 (prolonged)2
Erythromycin 17% 0.1%(daily)1 Filamentous bacteria,
  Vibrio spp. (33%)
0.5-0.61 Filamentous bacteria (17%)
22 Pseudomonas spp. (17%)
NA3 Vibrio spp. (17%)
22 Vibrio spp./
  Pseudomonas spp. (17%)
Formalin 49% 27 (0.5 h), 5-20 (1h) Ciliates (90%)
0.05 (daily)
Formalin + 0.01 + 0.01 Filamentous bacteria (10%)
  malachite green
Furans 44% 2.0-2.5 (d)2 All types of bacteria (31%)
2-4 (prolonged) Luminous bacteria (19%)
3-10 (12 h)
3-4 d, 2-5 (daily)2
12 Fungi (25%)
NA (daily) Filamentous bacteria (6%)
2-5 Ciliates (6%)
Vibrio spp. (13%)
Malachite green 17% 1.0 Ciliates (50%)
NA Fungi (33%)
NA Luminous bacteria (17%)
________________________________________________________________________________________________________________________________________________________________
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antifungal agent is malachite green, used either alone or in combination with formalin (Table 1).
Treflan, malachite green and formalin have been widely used by many hatcheries as prophylactic
treatments for fungi and bacteria (Tables 1 and 2).  Some hatcheries used furans (of the furan users,
6.2%), erythromycin (of the erythromycin users, 16.7%), oxytetracycline (of the oxytetracycline users,
15%) or Treflan (of the Treflan users, 21.2%) for prophylactic treatment in larval rearing (Table 2).
Other than the prophylactic treatment strategy, it is not very clear whether the treatment strategies
adopted by the hatcheries surveyed are metaphylactic or therapeutic treatment strategies.
DISCUSSION
The actual strategy used in administration of a chemotherapeutant is an essential component of
proper management.  There are three basic types of strategy: prophylactic, metaphylactic and
therapeutic (Bell 1992).  Prophylactic treatment involves the routine use of a chemotherapeutant
prior to clinical signs of disease being noted.  In the present study, malachite green, Treflan and
furans were found to be used as prophylactic treatment even without an established history of
disease.  Prophylactic treatment is best used when a long history of disease allows for accurate
prediction (Bell 1992).  A metaphylactic strategy calls for treatment to be administered only after
a predetermined disease prevalence has been reached within the shrimp population and a full-scale
outbreak is therefore probable.  Therapeutic treatment relies upon the accurate diagnosis of the
disease, immediately followed by proper treatment.  Most of the drugs and chemotherapeutants
used in the hatcheries surveyed fall into neither the metaphylactic nor the therapeutic method of
administration.  Other than as prophylactic treatment, they were used based on observation of the
clinical signs of disease or after the occurrence of disease.  The determination of actual disease
prevalences and accurate diagnoses based on proper monitoring have not been done.  Such use of
drugs and chemotherapeutants without proper diagnosis leads to higher operating costs and the
production of poor quality postlarvae, and increases the risk of chemicals in the environment.
Table 2. Continued. . .
________________________________________________________________________________________________________________________________________________________________
Chemical % Users Dose (ppm) Pathogen





1-31 Vibrio spp. (15%)
4-52
4 Pseudomonas spp. (8%)
2 Filamentous bacteria (8%)
22 All bacteria (8%)
0.5-1(daily) Quarantine (8%)
Treflan 92% 0.003-0.0061 Fungi (64%)
0.02-0.12 (daily)
0.002-0.01 (daily) Bacteria (21%)




3NA = not available.
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Most of the chemicals that have been tested to control luminous vibriosis, such as chloramphenicol,
Furacin, and oxytetracycline, cause mortalities, incomplete molting, or morphological deformities,
such as spread carapace, bent rostrum, and curled setae in shrimp larvae when applied at effective
concentrations (Baticados et al. 1990b).  The present study reveals that the concentrations of
furans used to control luminous bacteria in Sri Lanka are lower than those reported in the literature
(Tables 2 and 3) (see Baticados and Paclibare 1992), and that oxytetracycline has not been used for
this purpose.  The concentrations of chloramphenicol used in Sri Lankan hatcheries to control
luminous vibrios are three to four times higher than those reported elsewhere (Ruangpan 1987,
Baticados and Paclibare 1992) and thereby increase the risk of morphological aberrations and
mortality.  Moreover, the use of chloramphenicol poses a danger to public health.  Chloramphenicol
has erythrocyte-destroying effects in humans (Fakas et al. 1982) and may be harmful to users who
come in contact with it (Baticados and Paclibare 1992).
Of the malachite green users, 50% used it as an antifungal and antibacterial agent and were unaware
of the concentrations used.  Similarly, 6% of the furan users and 17% of the erythromycin users used
these chemotherapeutants as antibacterial agents, and were unaware of the concentrations used
This indicates that some users are selecting arbitrary dosages of chemotherapeutants for use in
shrimp hatcheries, a practice which, if continued on a routine basis, may lead to the development
of resistant strains of pathogens and to associated economic losses.  Sixty-seven percent and 17% of
hatchery operators used malachite green in broodstock maintenance and in larval rearing,
respectively.  Malachite green has been used at levels of 0.002 to 0.01 ppm with varying success as
an antifungal agent in larval rearing (Bell and Lightner 1992).  Malachite green is reported to have
potential carcinogenic and teratogenic properties (Baily 1983).  As an alternate to malachite green,
trifluralin has been used at levels of 0.001 to 0.002 ppm with even more success, and with apparently
few, if any, side effects (Baticados et al. 1990a, Bell and Lightner 1992).
Sixty-four percent and 44% of the hatcheries, respectively, used oxytetracycline and furans to control
all types of bacteria.  The present survey also revealed that oxytetracycline and furans have been used
routinely on a daily basis.  Oxytetracycline is known to enhance the production of plasmid-mediated
resistance in aquatic bacteria (Shotts et al. 1976).  Nitrofurans (e.g., prefuran) may possibly cause
rapid formation of bacterial resistance because of their persistence in water (Beladi et al. 1978).  The
prolonged, repeated or widespread use of antibiotics more significantly leads to the development of
resistance in bacterial populations (Watanabe et al. 1971; Aoki 1974; Aoki et al. 1981, 1987).  Furans
(furozolidone) have been implicated as potential carcinogens (Schnick and Meyer 1978).
Chemotherapy is based on the principle of differential toxicity, i.e., the drug or chemical must kill
or eliminate the pathogen at concentrations that are not harmful to the host (Baticados and Paclibare
1992).  The effective concentration of 30 ppm formalin against protozoan infections of P. monodon
larvae and postlarvae was reported to be the 12 h LC50 value for larval P. monodon (Vicente et al.
1979).  Thus, the toxicity of drugs and chemicals limits their use as a method to control shrimp-
hatchery diseases.  The present survey revealed the use of 20 to 27 ppm formalin with .05-1.0 h
exposure periods.  Even though these concentrations are below the reported LC50 value, frequent use
of formalin at such concentrations may cause sublethal effects that may be seen in later larval stages.
CONCLUSIONS
It is clear that without proper scientific investigations into treatment regimes, there has been a
tendency for individual hatcheries to select their own treatment regimes and to do their own
experimentation.  Little knowledge exists among hatchery operators as to the potential hazardous
effects of the chemicals in use.  It is also evident that knowledge of alternate chemotherapeutants
with fewer or no side effects is lacking.  Since the chemotherapeutants used in aquaculture may
result in adverse environmental impacts such as quantitative and qualitative changes in bacterial
flora, toxic effects on wild living organisms, development of drug resistance in bacterial pathogens
The Use of Chemotherapeutic Agents in Shrimp Hatcheries in Sri Lanka
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Table 3. Chemotherapeutants and their usage in shrimp hatcheries as reported in the literature.
_____________________________________________________________________________________________________________________________________________________________________
Chemical/Drug Dosage Duration Pathogen Stage References
(ppm)
Chloramphenicol 2-3 5 d Vibrio harveyi PL 6-7 Ruangpan 1987
2.7-7 Prolonged Bacteria PL 2-15 Rattanavinijkul et al.
  1988
2-41 Every other d Luminous bacteria PL Baticados and Paclibare
  1992
1.01 Every 3 d Bacteria PL Sunaryanto 1986
2-61 Every 2 d Bacteria PL Aquacop 1983
2-10 Bacteria PL Aquacop 1983
Erythromycin 2-4 3-5 d bath Bacteria Larvae Baticados and Paclibare
  1992
Formalin 25-75 Prolonged Ectoparasites Juveniles Limsuwan 1987
25-30 24 h Epistylis Juveniles Chen 1978
50-100 30 min Epistylis Juveniles Ruangpan 1982
25 10-15 min Disinfectant Spawners Platon 1978
2-5 Routine bath Bacteria, parasites Larvae Baticados and Paclibare
  1992
Furans 1.0 Prolonged Vibrio Larvae Limsuwan 1987
(furazolidone, 2.0, 0.51 Prolonged Bacteria Larvae Primpol 1990
  Furacin)
10-20 24 h Vibrio harveyi Larvae Batcados and Paclibare
  1992
0.5-1.0 Routine Bacteria Larvae
50 24 h Bacteria Larvae Baticados et al. 1990b
0.1 Every other d Bacteria PL Aquacop 1977
3.0 Few h Disinfectant Spawners Platon 1978
5-10 NA Lagenidium spp. Larvae Lio-Po et al. 1982
Malachite green 0.01 Fungi Larvae SCSP 1982
0.006 Fungi Mysis Ruangpan 1982
0.5 10 min Disinfectant Eggs Kungvankij et al. 1986
0.007 Bacteria, parasites PL Baticados and Paclibare
  1992
Oxytetracycline 2.68-5 Prolonged Bacteria PL Rattanavinijkul et al.
  1988
1.5 Every other d Vibrio harveyi PL Baticados and Paclibare
  1992
100 24 h Vibrio harveyi Nauplius
Trifluralin (Treflan) 0.01 Few h Fungi Eggs Ruangpanich 1988
0.2 Prolonged Lagenidium spp. Larvae Limsuwan 1987
0.1 Every 2-3 d Lagenidium spp. Eggs Baticados et al. 1990a
0.2 24 h Lagenidium spp. PL Baticados et al. 1990a
0.1 Every 2-3 d Lagenidium spp. Larvae Baticados et al. 1990a
for 24 h





of fish and shellfish, and transfer of resistance to human pathogens (Braaten and Hektoen 1991),
knowledge on the controlled use and careful selection of chemothrapeutants is imperative.
Although the Cosmetics, Devices and Drugs Act No. 27 of 1980 controls the importation,
manufacture and sale of chemotherapeutic agents including antibiotics and disinfectants, the
implementation of such legislation does not appear to be very effective (Subasinghe 1992).  Since
chemotherapeutants are readily available through pharmaceutical outlets and as there exists no
legislation on the use of chemotherapeutants in aquaculture in Sri Lanka, legislation to regulate
the use of chemotherapeutic agents in aquaculture is essential.  Moreover, a program should be
initiated to disseminate knowledge on the potential health hazards and known efficacies of
chemotherapeutants used in aquaculture.  Research is needed to determine the efficacies of the
wide range of chemotherapeutants used in aquaculture and their residual patterns in cultured
shrimp and wild fish and shellfish.
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